ArticleJournal of neuro-oncology2026
Real-world outcomes of sacituzumab govitecan in patients with pretreated triple-negative breast cancer and brain metastases: data from CEBCC-102 study.
Justyna Żubrowska et al.PubMed ↗Publisher ↗
No numbers read from the abstract.